Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04891705 · ClinicalTrials.gov registry record
Point of Care Ultrasound Lung Artificial Intelligence (AI) Validation Data Collection Study
A clinical trial, sponsored by Philips Clinical & Medical Affairs Global.
- Completed
- Registry status
- 554
- Enrollment target
NCT04891705: Completed study, sponsored by Philips Clinical & Medical Affairs Global.
NCT04891705 is a clinical trial that has completed, run by Philips Clinical & Medical Affairs Global. The registered enrollment target is 554 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04891705 has completed, sponsored by Philips Clinical & Medical Affairs Global.
- COMPLETED
- Registry status
- 554 participants
- Enrollment target
Study Summary
This study is being conducted to collect image data and relevant clinical data from medical records of patients with suspicion of lung consolidation or pleural effusion. The information will be used to test the performance of Artificial Intelligence (AI) in identification of features associated with the above lung conditions.
Interventions
- DEVICE Lung Ultrasound Scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 554 participants |
| Start Date | 2021-09-11 |
| Est. Completion | 2023-12-14 |
What the finished NCT04891705 record still lists
NCT04891705 is an observational study that tracks outcomes without assigning an intervention. The registered 554 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Lung Ultrasound Scan is the first listed.
NCT04891705 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04891705 about?
NCT04891705 is a clinical study titled "Point of Care Ultrasound Lung Artificial Intelligence (AI) Validation Data Collection Study". This study is being conducted to collect image data and relevant clinical data from medical records of patients with suspicion of lung consolidation or pleural effusion. The information will be used to test the performance of Artificial Intelligence (AI) in identification of features associated with...
What is the current status of trial NCT04891705?
This trial is currently completed. The enrollment target is 554 participants. The study started on 2021-09-11. Estimated completion is 2023-12-14.
What interventions are being tested in trial NCT04891705?
The interventions under investigation include: Lung Ultrasound Scan (DEVICE).
Who is sponsoring clinical trial NCT04891705?
This trial is sponsored by Philips Clinical & Medical Affairs Global, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05786924 · 554 participants · Phase 1
Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- NCT06799000 · 555 participants · Phase 3
A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa (RECHARGE 1)
- NCT06840392 · 555 participants · Phase 3
A Phase 3 Study to Assess Efficacy Safety and Tolerability of Remibrutinib in Adult and Adolescent Patients With Moderate to Severe Hidradenitis Suppurativa
- NCT06074588 · 556 participants · Phase 3
Sacituzumab Tirumotecan (MK-2870) Versus Chemotherapy in Previously Treated Advanced or Metastatic Nonsquamous Non-small Cell Lung Cancer (NSCLC) With EGFR Mutations or Other Genomic Alterations (MK-2870-004)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI